Elpis Biomed Ltd.?(Elpis), a University of Cambridge spin-out developing high quality human cells via its proprietary OPTi-OX platform, is pleased to announce that the Company has been selected as winner in the category?Start-Up of the Year?at the?2018 Ca
During his plenary address, on ‘Opportunities in the Golden Age of Biology’, Dr Milner asked whether the drug discovery process is ‘broken’. Dr Milner explained...